<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">

Biopharma SERVICES

Diagnostic Research

Working alongside our biopharmaceutical partners, we employ personalized and integrated approaches to uncover new solutions to diagnostic challenges with industry-leading expertise in blood-based testing.

Uncovering the depth and breadth of disease biology

Our core belief is that no single technology will answer all diagnostic research questions that we encounter. We employ a blood-based, technology agnostic approach for diagnostic research to uncover novel insights about the tumor biology and patient’s immune response to cancer for biopharmaceutical therapeutics in clinical development. Our services support known target feasibility studies as well as unbiased diagnostic research to discover novel biomarkers of interest.
 
ai-platform
 

Our Technologies & Research Assays

MALDI-ToF Mass Spectrometry Liquid Chromatography Mass Spectrometry Enzyme-Linked Immunosorbent Assay Droplet Digital™ PCR Next Generation Sequencing

MALDI-ToF Mass Spectrometry

  • VeriStrat® Test
  • ImmunoStrat® Protein Signatures
  • Lung Cancer Risk of Recurrence Test
  • Biological Pathway Protein Score
  • Custom Signature Discovery
LEARN MORE ABOUT MALDI

Liquid Chromatography Mass Spectrometry

  • Nodify XL2® Lung Nodule Test
  • Lung Cancer Protein Panel
  • Alzheimer’s Protein Panel
  • Custom LC-MRM-MS Protein Panel
  • Unbiased DIA LC-MS/MS
  • Direct Neoantigen Characterization
LEARN MORE ABOUT LC-MS

Enzyme-Linked Immunosorbent Assay

    • Nodify CDT™ Lung Nodule Test
    • Platelia SARS-CoV-2 Total Ab Test
    • Custom ELISA Assay
LEARN MORE ABOUT ELISA

Droplet Digital™ PCR

  • GeneStrat® Test
    EGFR | EML4-ALK | ROS-1 | RET | KRAS | BRAF
  • Bio-Rad SARS-CoV-2 ddPCR Test
  • PD-L1 Expression Assay
  • Microsatellite Instability Assay
  • Custom Assay
LEARN MORE ABOUT DDPCR

Next Generation Sequencing

  • Pan-Cancer Cell-Free Assay
  • Cancer-Specific Assays (lung, breast, colon, myeloid, pediatric)
  • Tumor Mutation Burden Assay
  • Immune Response Assay
  • Immune Repertoire for TCR Beta Assay
Learn more about NGS

Our Unbiased Diagnostic Discovery Approach

In addition to traditional statistical methods used for known biomarker targets, we employ a unique approach to discover innovative diagnostic tests. We combine blood-based biological information related to the tumor, immune response, and host-status with clinical and radiomic data as inputs to our proprietary Diagnostic Cortex® AI platform, which enables us to interpret the holistic disease state of each patient or clinical dataset we encounter.

OUR PROPRIETARY AI PLATFORM

Biodesix_Graphic_1

Contact our biopharma services team to learn more about our capabilities to be your diagnostic research partner

Contact us